Previous 10 | Next 10 |
The following slide deck was published by Rockwell Medical, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Rockwell Medical, Inc. 2021 Q1 - Results - Earnings Call Presentation
According to Stock Traders Daily, a 20-year industry veteran, #investors can use the #priceaction in Rockwell Medical (NASDAQ: RMTI) to foretell upcoming changes. A current example is provided below. There are trading plans for RMTI, but the data on this page does not upda...
Rockwell Medical, Inc. (RMTI) Q1 2021 Earnings Conference Call May 17, 2021 4:30 PM ET Company Participants Claudia Styslinger – Investor Relations Russell Ellison – President and Chief Executive Officer Russell Skibsted – Executive Vice President, Chief Financial Officer...
-Home Infusion FPC Program expected to initiate Phase 2 trial in second half of 2021- -Company received marketing approval in Canada for Triferic AVNU™- -Conference call and webcast on Monday, May 17th at 4:30 p.m. ET- WIXOM, Mich., May 17, 2021 (GLOBE NEWSWIR...
When #institutionalinvestors make decisions to buy and sell #stocks they normally want to keep it quiet. However, if we pay close attention we can see what is going on, and make good decisions.. The Rockwell Medical (NASDAQ: RMTI) report below can help you understand how t...
WIXOM, Mich., May 03, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it will host a confer...
This is not EF Hutton, but it could be more #powerful. A picture speaks a thousand words, they say, and the #priceaction of Rockwell Medical (NASDAQ: RMTI) tells an important story. The movement tells us where investors perceive value, or the lack of it, and if we pay attent...
Rockwell Medical (RMTI) announces that its Triferic AVNU (ferric pyrophosphate citrate injection) received a marketing approval from Health Canada for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease.Shares up nearly 6%...
WIXOM, Mich., April 27, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that Triferic AVNU (ferr...
WIXOM, Mich., April 22, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it presented data f...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...